THOMAS BROWN: Open Payments
NPI 1144323049 · ITHACA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,087 in 62 payments from 14 companies in 2025. Trend: 2023 $816 · 2024 $1,230 · 2025 $1,087
Food & beverage: $1,077Education: $10
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 3 | $178 |
| Regeneron Healthcare Solutions, Inc. | 9 | $178 |
| Novartis Pharmaceuticals Corporation | 11 | $159 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $155 |
| ABBVIE INC. | 12 | $142 |
| Janssen Biotech, Inc. | 4 | $73 |
| GENZYME CORPORATION | 2 | $46 |
| PFIZER INC. | 2 | $37 |
| Lilly USA, LLC | 2 | $33 |
| UCB, Inc. | 1 | $22 |
Products named: DUPIXENT, OPZELURA, COSENTYX, ILUMYA, SKYRIZI, TREMFYA, RINVOQ, BLU-U.
Industry payments across NY — which companies pay providers there.
